Susan Hasty, Publisher
Table of Contents . . . October 21st, 1996Non-Subscriber - Summaries Only
Cancer Vaccines - Phase I/II Trial for MGV Cancer Vaccine Begins
Cancer Vaccines - Trial Approval Received for Ovarex Vaccine in Canada
Antisense Technology - Patent Received on Antisense Inhibitor of C-raf Kinase
Breast Cancer (Diagnostics) - FDA Status Update Announced for Cancer Test
Breast Cancer (Diagnostics) - Technology Offered for Improved Detection of Early Stage Cancer
Breast Cancer (Genetics) - Testing Availability for Cancer in Persons of Ashkenazi Jewish Descent
Breast Cancer (Screening) - Women with Breast Implants Can Receive Non-Surgical Biopsy
Carcinogenesis - Newly Discovered Gene Halts Cell Division and May Have Cancer Link
Colorectal Cancer (Diagnostics) - CEA-Scan Detection Agent Cleared for Sale in Europe
Colorectal Cancer (Diagnostics) - Clinical Trials of Blood-Based Cancer Test Begin
Esophageal Cancer (Therapy) - Availability of Photofrin for Injection Announced
Genetic Testing - Education Critical in Genetic Susceptibility Testing
Genetic Testing - Organization Calls for Strong Protections for Genetic Information Use
HBV Vaccines - Contract Awarded for Hepatitis B Adult Vaccine
Human Herpesvirus 8 (Screening) - Virus Appears Sexually Transmitted and Associated with Kaposi's Sarcoma
Human Papillomavirus Type 18 (Prognosis) - HPV-18 Is Independent Prognostic Factor in Cervical Cancer
Industry News (Acquisitions) - Anticancer Drug Acquired - To Be Sold in U.S. and Canada
Industry News (Clinical Trials) - CEP-2563 Phase I Cancer Study Launched
Industry News (Funding) - Grants Received To Scale-Up Manufacturing of Products
Industry News (Funding) - SBIR Development Grant Received for Improved Tumor Agent
Industry News (Genomics) - 40,000 Human Genes Discovered Using SBH Technology Reported
Industry News (Joint Venture) - MASDA Technology Used for Mutation Detection in Colorectal Cancer
Industry News (Joint Venture) - MRI Technique Commercialized for Breast Cancer Diagnosis and Therapy
Industry News (Licensing) - FAS Gene Licensed as Component of System
Industry News (Licensing) - Oncogene Ras Processing Inhibitors Licensed
Industry News (Patents and Technologies) - Allowance Notice Received for Licensed Cancer Technology
Industry News (Patents and Technologies) - Allowance Received for Reformulation Technology
Industry News (Patents and Technologies) - Notice of Allowance Received on U.S. Patent
International (Europe) - Young Europeans Unaware of Hepatitis B Risk
Leukemia (Treatment) - Hycamtin Achieves Promising Results in Patients
Pancreatic Cancer (Therapy) - FDA Approves Stehlin Foundation Anticancer Drug
Smoking Issues - Joint Research Initiative Tests Effects of LungCheck
Tumor Markers - ASCO Issues New Guidelines on Tests
Disease Associations - "Risk Factors and Outcome from Invasive Aspergillosis (IA)."
Opportunistic Infections - "Validation of a Clinical Prediction Model for Surgical Site Infection after Oncology Operations."
Vaccine Development (EBV) - "Recombinant EBV gp350 as a Subunit Vaccine Candidate to Prevent EBV-Related Disease."
Cancer Gene Therapy - "Active Site-Directed Double Mutants of Dihydrofolate Reductase."
Cancer Gene Therapy - "Constitutive Retinoid Receptors Expressed from Adenovirus Vectors That Specifically Activate Chromosomal Target Genes Required for Differentiation of Promyelocytic Leukemia and Teratocarcinoma Cells."
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.